Ann Neurol

1. FADDA G, Yea C, O'Mahony J, Waters P, et al
   Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease.
   Ann Neurol. 2024 Feb 27. doi: 10.1002/ana.26890.
   

   >> Share

   
   
2. SHU Y, Huang R, Li Q, Lu Y, et al
   Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with HLA-A*3303 and HLA-DPB1*0501.
   Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26899.
   

   >> Share

   
   

   
   Int J Clin Pract

3. FARJOUD KOUHANJANI M, Hosseini SA, Mousavi SM, Noroozi Z, et al
   Takotsubo Cardiomyopathy and Autoimmune Disorders: A Systematic Scoping Review of Published Cases.
   Int J Clin Pract. 2024;2024:7259200.
   

   >> Share

   
   

   
   J Nephrol

4. ARNAERT S, Schepens N, Deleu L, Malfait T, et al
   Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
   J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
   

   >> Share

   
   
5. VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
   Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
   J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
   

   >> Share

   
   

   
   J Neuroimmunol

6. KMEZIC I, Press R, Glenewinkel H, Doppler K, et al
   Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
   J Neuroimmunol. 2024;389:578326.
   

   >> Share

   
   
7. SERAFINI B, Benincasa L, Rosicarelli B, Aloisi F, et al
   EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.
   J Neuroimmunol. 2024;389:578314.
   

   >> Share

   
   
8. FRID K, Usmann A, Markovits-Pachter T, Binyamin O, et al
   Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis.
   J Neuroimmunol. 2024;389:578313.
   

   >> Share

   
   

   
   J Neurol

9. SCHERER L, Soudant M, Pittion-Vouyovitch S, Debouverie M, et al
   Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.
   J Neurol. 2024 Feb 29. doi: 10.1007/s00415-024-12266.
   

   >> Share

   
   
10. TOLJAN K, Briggs FBS
    Male sexual and reproductive health in multiple sclerosis: a scoping review.
    J Neurol. 2024 Feb 28. doi: 10.1007/s00415-024-12250.
    

    >> Share

    
    
11. LEAVITT VM, Tozlu C, Nelson KE, Boehme AK, et al
    A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis.
    J Neurol. 2024 Feb 28. doi: 10.1007/s00415-023-12147.
    

    >> Share

    
    
12. VAN DAM M, Krijnen EA, Nauta IM, Fuchs TA, et al
    Identifying and understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning.
    J Neurol. 2024 Feb 26. doi: 10.1007/s00415-024-12227.
    

    >> Share

    
    
13. NGUYEN TT, Chae J, Kang JJ, Oh SY, et al
    Saccadic fatigue as an early indicator for diagnosing myasthenia gravis.
    J Neurol. 2024 Feb 25. doi: 10.1007/s00415-024-12262.
    

    >> Share

    
    
14. WEISS MD, Freimer M, Leite MI, Maniaol A, et al
    Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
    J Neurol. 2024 Feb 24. doi: 10.1007/s00415-024-12209.
    

    >> Share

    
    

    
    Kidney Int

15. 
    KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
    Kidney Int. 2024;105.
    

    >> Share

    
    
16. FLOEGE J, Jayne DRW, Sanders JF, Tesar V, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.
    Kidney Int. 2024;105:447-449.
    

    >> Share

    
    

    
    Lancet Neurol

17. HEIDBREDER A
    Sleep matters in anti-LGI1 encephalitis.
    Lancet Neurol. 2024;23:221-223.
    

    >> Share

    
    

    
    Mult Scler

18. KRIEGER SC, Sinks S, Huang F, Steverson J, et al
    The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis.
    Mult Scler. 2024 Feb 26:13524585241232274. doi: 10.1177/13524585241232274.
    

    >> Share

    
    
19. MILLER AE
    Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?
    Mult Scler. 2024 Feb 27:13524585241233999. doi: 10.1177/13524585241233999.
    

    >> Share

    
    
20. NAKKEN O, Aarseth JH, Wergeland S, Stigum H, et al
    BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
    Mult Scler. 2024 Feb 27:13524585241230440. doi: 10.1177/13524585241230440.
    

    >> Share

    
    
21. LIM TRU, Kumaran SP, Suthiphosuwan S, Espiritu AI, et al
    Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis.
    Mult Scler. 2024 Feb 28:13524585241228426. doi: 10.1177/13524585241228426.
    

    >> Share

    
    
22. HEESEN C, Luhmann D
    Reply: Mobile health interventions in multiple sclerosis: A systematic review.
    Mult Scler. 2024 Feb 29:13524585241234777. doi: 10.1177/13524585241234777.
    

    >> Share

    
    
23. KARI S, Bucciarelli F, Angles T, Oster AC, et al
    Increased levels of circulating soluble CD226 in multiple sclerosis.
    Mult Scler. 2024 Feb 29:13524585241234489. doi: 10.1177/13524585241234489.
    

    >> Share

    
    
24. AFZAL RM, Romme Christensen J, Gynthersen RMM, Lebech AM, et al
    Neoehrlichiosis associated with ocrelizumab in a patient with multiple sclerosis: A case report.
    Mult Scler. 2024 Feb 29:13524585241235542. doi: 10.1177/13524585241235542.
    

    >> Share

    
    
25. GIULIANI G, Zilli C, Caramia F, Di Piero V, et al
    SUNCT syndrome secondary to multiple sclerosis: Not only trigeminal neuralgia.
    Mult Scler. 2024 Mar 1:13524585241235535. doi: 10.1177/13524585241235535.
    

    >> Share

    
    

    
    Neurology

26. AOTSUKA Y, Misawa S, Suichi T, Shibuya K, et al
    Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide Survey: Analyses of 1,257 Diagnosis-Confirmed Patients.
    Neurology. 2024;102:e209130.
    

    >> Share

    
    
27. MARRIE RA, Salter A
    Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials.
    Neurology. 2024;102:e208099.
    

    >> Share

    
    
28. LEMMENS CMC, van Amerongen S, Strijbis EM, Killestein J, et al
    Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e208032.
    

    >> Share

    
    
29. BOURDETTE D, Wooliscroft L
    The Challenges of Treating Late-Onset Multiple Sclerosis.
    Neurology. 2024;102:e209146.
    

    >> Share

    
    
30. MOURESAN EF, Mentesidou E, Berglund A, Mckay KA, et al
    Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Neurology. 2024;102:e208051.
    

    >> Share

    
    
31. 
    Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209252.
    

    >> Share

    
    

    
    PLoS One

32. LIU X, Xue J, Li T, Wu Q, et al
    Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    PLoS One. 2024;19:e0298269.
    

    >> Share

    
    

    
    Semin Hematol

33. KISHTAGARI A, Corty RW, Visconte V
    Clonal hematopoiesis and autoimmunity.
    Semin Hematol. 2024 Feb 2:S0037-1963(24)00011.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share